HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mei Lin Go Selected Research

sepantronium

6/2018The mechanistic effects of the dioxonaphthoimidazolium analog YM155 in renal cell carcinoma cell cycling and apoptosis.
1/2018Anti-survivin effect of the small molecule inhibitor YM155 in RCC cells is mediated by time-dependent inhibition of the NF-κB pathway.
1/2017Action of YM155 on clear cell renal cell carcinoma does not depend on survivin expression levels.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mei Lin Go Research Topics

Disease

8Neoplasms (Cancer)
06/2018 - 10/2006
3Renal Cell Carcinoma (Grawitz Tumor)
06/2018 - 01/2017
2Carcinoma (Carcinomatosis)
01/2021 - 03/2018
2Tuberculosis (Tuberculoses)
10/2020 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
10/2014 - 02/2011
1Malaria
11/2021
1Cholangiocarcinoma
01/2021
1Lung Diseases (Lung Disease)
02/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
10/2017
1Neuroinflammatory Diseases
10/2017
1Lung Neoplasms (Lung Cancer)
08/2016
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2012
1Glioma (Gliomas)
10/2006

Drug/Important Bio-Agent (IBA)

3Pharmaceutical PreparationsIBA
11/2021 - 10/2006
3sepantroniumIBA
06/2018 - 01/2017
2EnzymesIBA
01/2019 - 10/2017
2SurvivinIBA
01/2018 - 01/2017
2Proteins (Proteins, Gene)FDA Link
01/2017 - 08/2016
2Tyrosine Kinase InhibitorsIBA
08/2016 - 10/2014
2Phosphotransferases (Kinase)IBA
08/2016 - 10/2014
1CalciumIBA
11/2021
1erdafitinibIBA
01/2021
1infigratinibIBA
01/2021
1Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA
01/2021
1Type 1 Fibroblast Growth Factor Receptor (Fibroblast Growth Factor Receptor 1)IBA
01/2021
1spiroketalIBA
10/2020
1Clarithromycin (Biaxin)FDA LinkGeneric
02/2020
1Anthranilate SynthaseIBA
01/2019
1DiarylheptanoidsIBA
03/2018
1Phospholipases A2 (Phospholipase A2)IBA
10/2017
1LysophospholipidsIBA
10/2017
1arachidonyltrifluoromethaneIBA
10/2017
1Arachidonic Acid (Vitamin F)IBA
10/2017
1EicosanoidsIBA
10/2017
1Erlotinib Hydrochloride (CP 358,774)FDA Link
08/2016
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
10/2014
1Sorafenib (BAY 43-9006)FDA Link
10/2014
1OxindolesIBA
10/2014
1terameprocolIBA
11/2013
1LignansIBA
11/2013
1N-methylisoindigotinIBA
05/2012
1indirubinIBA
05/2012
1ResveratrolIBA
02/2011
1StilbenesIBA
11/2010
1Therapeutic UsesIBA
10/2006
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
10/2006
1Sulfoglycosphingolipids (Sulfatides)IBA
10/2006
1LigandsIBA
10/2006
1GlycosphingolipidsIBA
10/2006
1Glycoproteins (Glycoprotein)IBA
10/2006
1Liposomes (Liposome)IBA
10/2006
1Drug CarriersIBA
10/2006

Therapy/Procedure

1Therapeutics
10/2014